Summit Therapeutics Stock (NASDAQ: SMMT) stock price, news, charts, stock research, profile.
Open | $8.90 |
Close | $9.31 |
Volume / Avg. | 1.90M / 4.14M |
Day Range | 8.80 - 9.36 |
52 Wk Range | 1.52 - 11.25 |
Market Cap | $6.54B |
P/E Ratio | 24.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 63 |
Short Interest | 24.38% |
Days to Cover | 6.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Summit Therapeutics (NASDAQ:SMMT) through any online brokerage.
Other companies in Summit Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS) and Ionis Pharmaceuticals (NASDAQ:IONS).
There is no analysis for Summit Therapeutics.
Summit Therapeutics has a consensus price target of $13.50.
The stock price for Summit Therapeutics (NASDAQ: SMMT) is $9.32 last updated July 17, 2024 at 7:44 PM EDT.
There are no upcoming dividends for Summit Therapeutics.
Summit Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Summit Therapeutics.
Summit Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.